C

Cencora

Distributes medicines and supports patient care

Full Stack Engineer 2

Full-TimeUpdated on 10/22/2026Deadline 10/31/26
$62.4k - $97.9k
Junior
Bachelor's
Delaware, USA+4 moreMore locations: Maryland, USA | North Carolina, USA | New Jersey, USA | Conshohocken, PA, USA
Remote
Software EngineeringFull-Stack Engineering

About the job

Requirements
  • A bachelor's degree in computer science, software engineering, systems engineering, information technology, or a related field, or equivalent experience.
  • At least 2 years of professional experience in full stack software development.
  • Hands-on experience with Databricks, including Spark, notebooks, and Delta Lake.
  • Experience with Azure DevOps for CI/CD, version control, and work item tracking.
  • Experience with Azure cloud services, including Data Factory, Synapse, Functions, and App Services.
  • Strong SQL skills and experience with relational or NoSQL databases.
  • Frontend experience with React, Angular, or Vue, and backend experience with Node.js, Python, Java, or .NET.
  • Ability to communicate with non-technical stakeholders and gather requirements.
  • Experience with Git-based version control and Agile/Scrum workflows.
  • Ability to write and optimize complex SQL queries, including joins, aggregations, indexing, and subqueries.
  • Understanding of database schemas, normalization, and basic data modeling.
  • Ability to handle data transformation logic between databases, backend APIs, and front-end states.
  • Experience with RESTful APIs and basic integration concepts.
  • Experience using version control systems, testing frameworks, and Agile development practices.
  • Understanding of software development lifecycle concepts, debugging, and quality code practices.
  • Problem-solving, communication, and teamwork skills.
Responsibilities
  • Design, develop, and maintain front-end and back-end components of web applications.
  • Build and consume RESTful and GraphQL APIs that integrate with internal and external data sources.
  • Write clean, tested, maintainable code following team standards.
  • Debug and resolve issues across the application stack.
  • Build and optimize data pipelines and notebooks in Databricks using Python, PySpark, and SQL.
  • Support ETL/ELT processes to move and transform data across environments.
  • Perform data analysis to support product, engineering, and business decisions by identifying trends, anomalies, and actionable insights.
  • Build LLM-powered application features, apply prompt engineering, manage model behavior and token budgets, and design reliable production AI interactions.
  • Integrate RAG pipelines and vector search components into application layers, collaborating with data scientists to ensure retrieval quality meets application requirements.
  • Use AI coding assistants to accelerate development, testing, and code review; critically validate generated code and apply engineering discipline.
  • Analyze application telemetry, load times, bundle sizes, and query execution plans to identify bottlenecks.
  • Translate product KPIs or user metrics into technical tracking requirements, such as event logging and monitoring.
  • Manage CI/CD pipelines using Azure DevOps Boards, Repos, Pipelines, and Artifacts.
  • Participate in release management, environment configuration, and deployment automation.
  • Monitor application and pipeline health and troubleshoot build and deployment failures.
  • Partner with business stakeholders to gather requirements and clarify data and reporting needs.
  • Translate business questions into technical specifications, data models, or dashboard requirements.
  • Present findings, dashboards, or technical updates to technical and non-technical audiences.
  • Collaborate with product managers, designers, and engineers in sprint planning and reviews.
  • Participate in code reviews and uphold engineering best practices.
  • Write and maintain technical documentation, including data dictionaries, pipeline documentation, and runbooks.
  • Mentor junior engineers on specific tasks as needed.
Desired Qualifications
  • Familiarity with data warehousing concepts, including star schema and dimensional modeling.
  • Exposure to Python-based data analysis, including pandas and PySpark.
  • Experience building AI/BI dashboards, reports, or traditional dashboards using Databricks or Power BI.
  • Prior experience in a hybrid engineering and analytics role.

About the company

Cencora buys and distributes medicines for pharmacies, hospitals and physician practices, while helping drug manufacturers bring treatments to patients. Its businesses combine wholesale supply networks with specialty distribution for complex therapies and services that support prescribing and patient access. Customers order medicines through its distribution systems, and its teams manage sourcing, storage and delivery alongside pharmacy operations and manufacturer support. It earns revenue from pharmaceutical sales and fees for logistics and healthcare services. The parent company was formed in 2001 through the merger that created AmerisourceBergen, adopted the Cencora name in 2023, and is headquartered in Conshohocken, Pennsylvania.

Company Size

10,001+

Company Stage

IPO

Headquarters

Conshohocken, Pennsylvania

Founded

2001

Get referred to Cencora

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Pharmacy contracts deepen customer ties: Cencora negotiates insurer agreements and handles administrative work through its managed-care networks.
  • Eligible US staff gain retirement support: Cencora counts student-loan payments toward its employer match, up to 4% of pay.
  • Drug demand expands sales: Cencora reported 5.1% quarterly revenue growth in August 2026, led by higher US volumes.

What critics are saying

  • Customer dependence concentrates risk: Walgreens and Boots supplied 25% of Cencora's fiscal 2025 revenue, reported in November 2025.
  • Legal liabilities tie up cash: Cencora's November 2025 filing recorded $4.3 billion in opioid settlements, payable over 13 years.
  • Warehouse work is physical: Cencora's day-shift associate listing requires repeated lifting up to 50 pounds and overtime availability.

What makes Cencora unique

  • Independent pharmacies get a shared brand: Cencora's Good Neighbor Pharmacy franchise supports their merchandising and store identity.
  • Specialty shipments use reusable packaging: Cencora's World Courier Cocoon containers combine passive temperature control with live location monitoring.
  • Medicines arrive ready for bedside checks: Cencora's American Health Packaging sells barcoded unit doses that support hospital scanning.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Parental Leave
  • Adoption Assistance
  • Infertility Coverage
  • Family Planning Benefits
  • Behavioral Health Solutions
  • Professional Development Budget
  • Training Programs

Company News

Financial News
Oct 21st, 2026
Cencora to buy American Oncology Network in $2.4bn deal

Cencora agrees to buy American Oncology Network for $2.4bn enterprise value, but a stockholder rollover means it may land only 75% of the company.

Yahoo Finance
Oct 16th, 2026
Cencora stock: $332.8B revenue, 14.4% EPS growth and 50.2% ROIC

Cencora, the pharmaceutical distributor formerly known as AmerisourceBergen, has risen 6% to $341.69 per share over the past six months. The S&P 500 gained 9.7% in the same period. The New York Stock Exchange-listed company (NYSE:COR) connects drug manufacturers with healthcare providers and offers logistics, data analytics, and consulting services. It rebranded in 2023. Its revenue reached $332.8 billion over the past 12 months, giving it scale and bargaining power with suppliers. That matters in a low-margin, volume-driven business. Earnings per share grew at a 14.4% compound annual rate over five years, outpacing 10.2% annualised revenue growth. Its five-year average return on invested capital was 50.2%. The shares trade at 17.4 times forward earnings.

Associated Press
Sep 2nd, 2026
Cencora launches cell and gene therapy service to help health systems scale advanced treatment programmes

Cencora has launched Cell and Gene Therapy Enablement through its Accelerate Pharmacy Solutions division to help health systems develop and expand cell and gene therapy programmes. The service provides support across financial planning, operational readiness, and scalable growth to reduce care barriers and improve patient access to advanced therapies. More than 35 cell and gene therapies have received FDA approval, with over 1,700 clinical trials underway globally. However, only 4% of health system pharmacy leaders report being fully prepared to integrate these treatments, highlighting infrastructure gaps. The offering includes market assessments, readiness evaluations, governance design, and workflow planning. Cencora, ranked number 10 on the Fortune 500 with over $300 billion in annual revenue, already provides specialty pharmaceutical services across the therapy lifecycle.

Yahoo Finance
Aug 14th, 2026
Cencora beats Q2 profit estimates as specialty pharma platform drives growth

Cencora reported second-quarter revenue of $84.75 billion, slightly above analyst estimates of $84.43 billion, representing 5.1% year-on-year growth. Adjusted earnings per share came in at $4.48, beating consensus estimates of $4.35 by 3%. Management attributed the performance to strength in specialty pharmaceuticals, particularly through Management Services Organisations like OneOncology and RCA. CEO Robert Mauch highlighted the company's positioning in specialty care, stating, "Our specialty platform supports growth across the healthcare ecosystem." The company raised its full-year adjusted EPS guidance to $17.85 at the midpoint. Operating margin held steady at 1.3%, matching the same quarter last year. During the earnings call, analysts questioned management about biosimilar opportunities, specialty logistics competition, and potential policy risks from proposed ASP rule changes.

Yahoo Finance
Aug 12th, 2026
Cencora raises FY2026 guidance after Q3 EPS jumps 12%, buys back $1B in shares

Cencora reported strong third-quarter results for fiscal year 2026, driven by execution across its business units and investments in its specialty positioning. The pharmaceutical distributor achieved double-digit adjusted operating income growth and 12% earnings per share growth in the quarter. The company conducted $1 billion in opportunistic share repurchases during the period. Based on its performance and confidence in continued execution, Cencora raised its fiscal 2026 EPS guidance. President and CEO Robert Mauch credited the results to the company's team members and their commitment to providing solutions for customers. He highlighted the strength of Cencora's portfolio and its pharmaceutical-centric strategy as the company approaches the end of its fiscal year. The earnings call was held on 5 August 2026, with senior leadership including Mauch and CFO Eva Boratto participating.